{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:05:09Z","timestamp":1759334709951,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.arcmed.2024.102961","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T12:53:53Z","timestamp":1706619233000},"page":"102961","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["De Novo Vitiligo Following Covid-19 Infection and Vaccination: A Door Open to Future Events?"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6237-6754","authenticated-orcid":false,"given":"Raffaella","family":"Mormile","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2024.102961_bib0001","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.3390\/vaccines10101647","article-title":"Vitiligo-like Lesions and COVID-19: Case Report and Review of Vaccination- and Infection-Associated Vitiligo","volume":"10","author":"Macca","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.arcmed.2024.102961_bib0002","doi-asserted-by":"crossref","first-page":"e15196","DOI":"10.1111\/dth.15196","article-title":"Sudden onset of vitiligo after COVID-19 vaccine","volume":"35","author":"Ciccarese","year":"2022","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.arcmed.2024.102961_bib0003","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1111\/jocd.14843","article-title":"Newly-developed vitiligo following COVID-19 mRNA vaccine","volume":"21","author":"U\u011furer","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.arcmed.2024.102961_bib0004","doi-asserted-by":"crossref","first-page":"e15502","DOI":"10.1111\/dth.15502","article-title":"COVID-19 and autoimmune phenomena: Vitiligo after Astrazeneca vaccine","volume":"35","author":"L\u00f3pez Riquelme","year":"2022","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.arcmed.2024.102961_bib0005","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1002\/ski2.86","article-title":"New-onset vitiligo following COVID-19 disease","volume":"2","author":"Herzum","year":"2022","journal-title":"Skin Health Dis"},{"key":"10.1016\/j.arcmed.2024.102961_bib0006","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2174\/1573396316666201210125858","article-title":"Vitiligo: An Updated Narrative Review","volume":"17","author":"Leung","year":"2021","journal-title":"Curr Pediatr Rev"},{"key":"10.1016\/j.arcmed.2024.102961_bib0007","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/jocd.15550","article-title":"Various aspects of the relationship between vitiligo and the COVID-19 pandemic or SARS-CoV-2 vaccines: Clinical pearls for dermatologists","volume":"22","author":"Aryanian","year":"2023","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.arcmed.2024.102961_bib0008","doi-asserted-by":"crossref","first-page":"e59782","DOI":"10.1371\/journal.pone.0059782","article-title":"Vitiligo: a possible model of degenerative diseases","volume":"8","author":"Bellei","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.arcmed.2024.102961_bib0009","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/jcmm.12206","article-title":"SIRT1 regulates MAPK pathways in vitiligo skin: insight into the molecular pathways of cell survival","volume":"18","author":"Becatti","year":"2014","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.arcmed.2024.102961_bib0010","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1073\/pnas.94.7.3302","article-title":"Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway","volume":"94","author":"Goillot","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2024.102961_bib0011","doi-asserted-by":"crossref","first-page":"105","DOI":"10.11648\/j.cmr.20130205.13","article-title":"Lymphocytic Expression of Fas and FasL Apoptotic Markers in Vitiligo","volume":"2","author":"Saleh","year":"2013","journal-title":"Clinical Medicine Research"},{"key":"10.1016\/j.arcmed.2024.102961_bib0012","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1038\/jid.2008.161","article-title":"Functional polymorphisms of the FAS gene associated with risk of vitiligo in Chinese populations: a case-control analysis","volume":"128","author":"Li","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.arcmed.2024.102961_bib0013","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/exd.14053","article-title":"Fas-FasL interaction in cytotoxic T cell-mediated vitiligo: The role of lesional expression of tumor necrosis factor-\u03b1 and interferon-\u03b3 in Fas-mediated melanocyte apoptosis","volume":"29","author":"Jimbo","year":"2020","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.arcmed.2024.102961_bib0014","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3389\/fimmu.2017.00403","article-title":"Dual Role of Fas\/FasL-Mediated Signal in Peripheral Immune Tolerance","volume":"8","author":"Yamada","year":"2017","journal-title":"Front. Immunol"},{"key":"10.1016\/j.arcmed.2024.102961_bib0015","doi-asserted-by":"crossref","first-page":"e 13167","DOI":"10.1111\/aji.13167","article-title":"SIRT1 negatively regulates invasive and angiogenic activities of the extravillous trophoblast","volume":"82","author":"Lee","year":"2019","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.arcmed.2024.102961_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.779177","article-title":"SIRT1: A Potential Therapeutic Target in Autoimmune Diseases","volume":"12","author":"Shen","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.arcmed.2024.102961_bib0017","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1111\/bph.15477","article-title":"Nicotinamide adenine dinucleotide metabolism in the immune response, autoimmunity and inflammageing","volume":"179","author":"Navarro","year":"2022","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.arcmed.2024.102961_bib0018","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3390\/cells12060936","article-title":"The Role of Oxidative Stress in Vitiligo: An Update on Its Pathogenesis and Therapeutic Implications","volume":"12","author":"Chang","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.arcmed.2024.102961_bib0019","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1111\/jcmm.17222","article-title":"NAD+ ameliorates endotoxin-induced acute kidney injury in a sirtuin1\u2013dependent manner via GSK-3\u03b2\/Nrf2 signalling pathway","volume":"26","author":"He","year":"2022","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.arcmed.2024.102961_bib0020","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41586-021-03841-4","article-title":"Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine","volume":"597","author":"Oberhardt","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2024.102961_bib0021","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41591-020-01143-2","article-title":"Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells","volume":"27","author":"Schulien","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.arcmed.2024.102961_bib0022","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.3390\/cancers13153800","article-title":"Post-Vaccination Anti-SARS-CoV-2-Antibody Response in Patients with Multiple Myeloma Correlates with Low CD19+ B-Lymphocyte Count and Anti-CD38 Treatment","volume":"13","author":"Ghandili","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.arcmed.2024.102961_bib0023","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/s41423-022-00887-w","article-title":"SARS-CoV-2 virus NSP14 Impairs NRF2\/HMOX1 activation by targeting Sirtuin 1","volume":"19","author":"Zhang","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.arcmed.2024.102961_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.597959","article-title":"CD38: An Immunomodulatory Molecule in Inflammation and Autoimmunity","volume":"11","author":"Piedra-Quintero","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.arcmed.2024.102961_bib0025","doi-asserted-by":"crossref","first-page":"8743","DOI":"10.18632\/aging.102385","article-title":"CD38-NAD+-SIRT1 axis in T cell immunotherapy","volume":"11","author":"Chatterjee","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.arcmed.2024.102961_bib0026","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1152\/physrev.00007.2021","article-title":"Implications of the NADASE CD38 on COVID Pathophysiology","volume":"102","author":"Zeidler","year":"2022","journal-title":"Physiol Rev"},{"key":"10.1016\/j.arcmed.2024.102961_bib0027","doi-asserted-by":"crossref","DOI":"10.1002\/bies.202000331","article-title":"Cancer as a prospective sequela of long COVID-19","volume":"43","author":"Saini","year":"2021","journal-title":"Bioessays"},{"key":"10.1016\/j.arcmed.2024.102961_bib0028","doi-asserted-by":"crossref","first-page":"8743","DOI":"10.18632\/aging.102385","article-title":"CD38-NAD+-Sirt1 axis in T cell immunotherapy","volume":"11","author":"Chatterjee","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.arcmed.2024.102961_bib0029","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13046-022-02421-2","article-title":"Expanding anti-CD38 immunotherapy for lymphoid malignancies","volume":"41","author":"Wang","year":"2022","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440924000146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440924000146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:52:49Z","timestamp":1759261969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440924000146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0188440924000146"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2024.102961","relation":{},"ISSN":["0188-4409"],"issn-type":[{"type":"print","value":"0188-4409"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"De Novo Vitiligo Following Covid-19 Infection and Vaccination: A Door Open to Future Events?","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2024.102961","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102961"}}